Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropy1 and 4-fluoro-substituted analogues in rat

References

• Agarwal D. K., Lawrence W. H., Nunezi L. T., Aution J. Mutagenicity evaluation of phthalic esters and metabolites. Journal of Toxicology and Environmental Health 1985; 16: 61–69
   PubMed Web of Science ®Google Scholar
• Azarnoff D. L., Reddy J. K., Hignite C., Fitzgerald T. Structure-activity relationships of clofibrate-like compounds on lipid metabolism. Proceedings of the Sixth International Congress of Pharmacology, H. Vapaatalo. Pergamon, New York 1975; vol. 4: 137–147
   Google Scholar
• Bieber L. L., Abraham T., Helmrath T. A rapid spectrophotometric assay for carnitine palmitoyltransferase. Analytical Biochemistry 1972; 50: 509–518
   PubMed Web of Science ®Google Scholar
• Bock P. P., Kramer R., Paveka M. In peroxisomes and related particles. Cell Biology Monographs 7. Springer, Berlin 1980; 44–74
   Google Scholar
• Bronfman M., Inestrosa N. C., Leighton F. Fatty acid oxidation by human liver peroxisomes. Biochemical and Biophysical Research Communications 1979; 88: 1030–1036
   PubMedGoogle Scholar
• Esbenshade T. A., Kammana V. S., Newman H. A. I., Torterella V., Witiak D. T., Feller D. R. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Biochemical Pharmacology 1990; 40: 1263–1274
   PubMedGoogle Scholar
• Furakawa K., Numoto S., Furuya K., Furakwa N. T., Williams G. M. Effects of the hepatocarcinogen Nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Cancer Research 1985; 45: 5011–5019
   PubMed Web of Science ®Google Scholar
• Glauert H. P., Reddy J. K., Kennam W. S., Salter G. L., Subbarao V., Pitot H. C. Effects of hypolipidaemic drugs on unscheduled DNA synthesis in cultured hepatocytes and mutagenesis in Salmonella. Cancer Letters 1984; 24: 147–156
   PubMed Web of Science ®Google Scholar
• Graham M. J., Wilson S. A., Winham M. A., Spencer A. J., Rees J. A., Old S. L., Bonner F. W. Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for three years. Fundamental and Applied Toxicology 1994a; 22: 58–64
   PubMedGoogle Scholar
• Graham M. J., Winham M. A., Harpur E. S., Bonner F. W., Gray T. J. B. The relative hypolipidaemic activity and hepatic effects of ciprofibrate enantiomers in the rat. Biochemical Pharmacology 1994b; 48: 2163–2171
   PubMedGoogle Scholar
• Habig W. H., Pabst M. J., Jakoby W. Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 1974; 249: 7130–7139
   PubMed Web of Science ®Google Scholar
• Lake B. G., Evans J. G., Gray T. J. B., Korosi S. A., North C. J. Comparative studies on Nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig and marmoset. Toxicology and Applied Pharmacology 1989; 99: 148–160
   PubMed Web of Science ®Google Scholar
• Lawrence R. A., Burke R. F. Glutathione peroxidase activity in selenium deficient rat liver. Biochemical and Biophysical Research Communications 1976; 71: 952–958
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Roseborough N. J., Farr A. L., Randall R. J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Makowska J. H., Bonner F. W., Gibson G. G. Comparative induction of cytochrome P450VA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset. Archives of Toxicology 1991; 65: 106–113
   PubMed Web of Science ®Google Scholar
• Makowska J. H., Gibson G. G., Bonner F. W. Species differences in ciprofibrate induction of hepatic cytochrome 4504A1 and peroxisome proliferation. Journal of Biochemical Toxicology 1992; 7: 183–191
   PubMedGoogle Scholar
• Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di-(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylindo)-2-pyrimid-inylthio] acetic acid (Wy-14,643) in rats. Cancer Research 1988; 48: 6739–6744
   PubMed Web of Science ®Google Scholar
• Nemali M. R., Reddy M. K., Usuda N., Reddy P. G., Comeau L. D., Rao M. S., Reddy J. K. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicology and Applied Pharmacology 1989; 97: 72–87
   PubMed Web of Science ®Google Scholar
• Paine A. J., Hockin L. J., Legg R. F. Relationship between the ability of nicotinamide to maintain nicotinamide adenine dinucleotide in rat liver cell culture and its effect on cytochrome P-450. Biochemical Journal 1979; 184: 461–463
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Lalwani N. D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Critical Reviews in Toxicology 1983; 12: 1–58
   Web of Science ®Google Scholar
• Reddy J. K., Lalwani N. D., Qureshi S. A., Reddy M. K., Moehle C. M. Induction of hepatic peroxisome proliferation in non-rodent species, including primates. American Journal of Pathology 1984; 114: 171–183
   PubMed Web of Science ®Google Scholar
• Sharma R., Lake B. G., Gibson G. G. Induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl) phthalate. Biochemical Pharmacology 1988; 37: 1203–1206
   PubMed Web of Science ®Google Scholar
• SAS/Stat*. User's Guide: Version 6, 4th edn. SAS Institute, Cary 1990
   Google Scholar
• Warren J. R., Simon V. F., Reddy J. K. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]-thymidine and Salmonella mutagenesis assays. Cancer Research 1980; 40: 36–41
   PubMed Web of Science ®Google Scholar
• Mathur S., Barradas M. A., Mikhailidis D. P., Dandona P. The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetes: a pilot study. Diabetes Research 1990; 14: 133–138
   PubMedGoogle Scholar